Latest Anorectics Stories
NEW YORK, April 15, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased Orexigen Therapeutics, Inc.
NORCROSS, Ga., April 7, 2015 /PRNewswire/ -- Hi-Tech Pharmaceuticals, Inc.
Results Show Proprietary Weight Loss and Energy Ingredient Found to be over 20% Stronger than Previous Studies of 30mg Ephedrine NORCROSS, Ga., April 2, 2015 /PRNewswire/ -- Thermo-Rx® brand
NORCROSS, Ga., March 31, 2015 /PRNewswire/ -- Fastin Rapid Release® is a quantum leap in the field of weight loss backed by two clinical studies -- one showed an increase in the metabolism
SAN DIEGO, March 30, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced that Tom Cannell has joined as Chief Commercial Officer.
-- Collaboration combines Intarcia's proprietary delivery technologies with Numab's novel multi-specific antibody technology to broaden and strengthen Intarcia's pipeline BOSTON and
NEW YORK, March 6, 2015 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Orexigen
WILMINGTON, Del., March 6, 2015 /PRNewswire/ -- Lucerne Biosciences, LLC announced today the U.S. Patent and Trademark Office's publication of U.S. Patent Application No.
- Contrave® net sales total $6.5 million in first 10 weeks of launch SAN DIEGO, Feb. 25, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
SAN DIEGO, Feb. 9, 2015 /PRNewswire/ -- Orexigen Therapeutics, Inc.
- Growing in low tufty patches.